eScholarship
metadata only
No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer
OBJECTIVE: Clinical genetic testing is commercially available for rs61764370, an inherited variant residing in a KRAS 3' UTR microRNA binding site, based on suggested associations with increased ovarian and breast cancer risk as well as with survival time. However, prior studies, emphasizing particu
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- High-fidelity rare structural variant detection with HiFiRE3 reduced representation via restriction enzyme ends#407657
- Study on the microRNA Expression Level in Postmenopausal Osteoporosis#869409
- Deep Learning Approaches Leveraging Sequence-Structure Representations for Human microRNA Precursors Cleavage Site Prediction#468535
- Deep Learning Approaches Leveraging Sequence-Structure Representations for Human microRNA Precursors Cleavage Site Prediction#468507
- keelyji/SNIP-R: v1.0.0 - Code for Ji et al., Nature Communications#1181476
Record · ID 1379526
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive